Upgrade to SI Premium - Free Trial

Chemours (CC) PT Lowered to $62 at Barclays

August 6, 2018 4:48 AM

Barclays lowered its price target on Chemours (NYSE: CC) to $62.00 (from $64.00) while maintaining a Overweight rating.

Categories

Analyst PT Change

Next Articles